… We are unaware of any studies with PAH in preterm neonates. In vitro studies with stably …
PIP and TAZ were obtained for 8 IV dosed preterm neonates with 4 more blood samples (…

… in the field of neonatal pharmacology during ECMO. We will … midazolam as probe drug (67).
Such observations should be considered while prescribing drugs for critically ill neonates on …

… Pharmacology suite, for preterm neonates from 24 weeks onwards. This model was subsequently
explored and tested based on intravenous … datasets on alfentanil, midazolam, caffeine, …

… It has a favourable pharmacokinetic (PK) and pharmacodynamic (PD) profile, which has
resulted in it becoming the most commonly used intravenous anaesthetic for the past three …

… of intravenous rifampin in infants of <121 days postnatal age (PNA). We enrolled 27 infants;
… However, as mentioned above, there are no specific PK/pharmacodynamic targets against S…

… the increased permeability in preterm infants is short-lived, … in neonates means that onset
time after intravenous induction … in neonates and premature infants in whom midazolam is not …

… agents or sedatives (midazolam, dexmedetomidine). All these … pharmacodynamic models
for commonly used intravenous … Pharmacokinetic and pharmacodynamic study of midazolam …

… (2.8%): a preterm newborn with … preterm newborn who died on day 4, following grade IV
brain hemorrhage. In that case, death was attributed to brain hemorrhage and not to midazolam …

… Morphine pharmacodynamics in mechanically ventilated preterm neonates undergoing …
The aim of the study was to investigate the pharmacokinetics of midazolam, after intravenous …

… to inadequate studies in preterm infants include difficulties in … The use of midazolam as
sedative in ventilated infants is … gaps in knowledge in neonatal pharmacology and the need for …